/
BMKDF
$0.39+$0.00 (+0.05%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.20 – $0.50
63% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.20
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $263.3K | $0 | $43.9K | $153.5K | $163.2K | $154.2K |
| Cost of revenue | $0 | $0 | $0 | $13.7K | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $263.3K | −$13.7K | $43.9K | $153.5K | $163.2K | $154.2K |
| Gross margin | — | — | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $58.2K | $56.4K | $42.3K | $118.4K | $497.8K | $545.8K | $650.5K | $696.0K |
| Operating income | −$726.7K | −$526.9K | −$1.2M | −$1.0M | −$1.4M | −$1.7M | −$1.3M | −$1.9M |
| EBITDA | −$660.6K | −$526.9K | −$1.2M | −$1.0M | −$1.2M | −$1.3M | −$919.0K | −$1.5M |
| Net income | −$726.7K | −$545.6K | −$1.2M | −$1.1M | −$1.5M | −$1.8M | −$1.4M | −$1.9M |
| Net margin | — | — | -461.6% | — | -3309.4% | -1200.2% | -874.5% | -1249.7% |
| EPS (diluted) | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.04
Price
$0.39
Implied downside
-91%
Peer comparison
BIOMARK DIAGNOSTICS INC
BIOMARK DIAGNOSTICS INC
Held by traders on TradeandTell
No one on the platform currently holds BMKDF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BMKDF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BMKDF yet.